Patrick Pauwels

Author PubWeight™ 66.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol 2008 1.91
2 Comparative analysis of dynamic cell viability, migration and invasion assessments by novel real-time technology and classic endpoint assays. PLoS One 2012 1.70
3 Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 2006 1.68
4 Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2002 1.65
5 Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis. J Natl Cancer Inst 2010 1.65
6 Absence of lymphangiogenesis in ductal breast cancer at the primary tumor site. Cancer Lett 2007 1.61
7 (99)mTc-(CO)(3) His-annexin A5 micro-SPECT demonstrates increased cell death by irinotecan during the vascular normalization window caused by bevacizumab. J Nucl Med 2011 1.55
8 Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res 2005 1.49
9 Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol 2011 1.41
10 EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations. Virchows Arch 2012 1.34
11 EGFR in melanoma: clinical significance and potential therapeutic target. J Cutan Pathol 2011 1.32
12 Array CGH analysis in primary gastrointestinal stromal tumors: cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status. Genes Chromosomes Cancer 2007 1.27
13 Array-based DNA methylation profiling for breast cancer subtype discrimination. PLoS One 2010 1.26
14 Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression through paracrine neuregulin 1/HER3 signalling. Gut 2012 1.19
15 Re: Plexiform angiomyxoid myofibroblastic tumor of the stomach. Am J Surg Pathol 2008 1.17
16 ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003 1.12
17 Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol 2007 1.12
18 Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas. BMC Cancer 2010 1.10
19 Prognostic role of vasculogenic mimicry in colorectal cancer. Dis Colon Rectum 2009 1.09
20 Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma. Blood 2002 1.05
21 Metastasized angiosarcoma of the spleen in a 2-year-old girl. Pediatr Hematol Oncol 2005 1.02
22 Immune Cells in Colorectal Cancer: Prognostic Relevance and Role of MSI. Cancer Microenviron 2011 0.99
23 Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria. J Thorac Oncol 2014 0.98
24 Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice? Cell Transplant 2010 0.98
25 Molecular analysis of primary gastric cancer, corresponding xenografts, and 2 novel gastric carcinoma cell lines reveals novel alterations in gastric carcinogenesis. Hum Pathol 2007 0.97
26 Fluorescence in situ hybridization study of chromosome 7 aberrations in hepatosplenic T-cell lymphoma: isochromosome 7q as a common abnormality accumulating in forms with features of cytologic progression. Genes Chromosomes Cancer 2002 0.96
27 Current challenges for the advancement of neural stem cell biology and transplantation research. Stem Cell Rev 2012 0.96
28 Differential impact of TGF-beta and EGF on fibroblast differentiation and invasion reciprocally promotes colon cancer cell invasion. Cancer Lett 2008 0.95
29 Inflammatory myofibroblastic tumor with ALK/TPM3 fusion presenting as ileocolic intussusception: an unusual presentation of an unusual neoplasm. Hum Pathol 2005 0.94
30 Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics 2013 0.94
31 Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008. Int J Gynecol Cancer 2012 0.93
32 Gastrin-releasing peptide receptor imaging in human breast carcinoma versus immunohistochemistry. J Nucl Med 2008 0.92
33 Expression analysis on archival material revisited: isolation and quantification of RNA extracted from FFPE samples. Diagn Mol Pathol 2013 0.92
34 Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site. Mod Pathol 2004 0.91
35 Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer. Curr Pharm Biotechnol 2014 0.91
36 Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer? Expert Rev Anticancer Ther 2014 0.91
37 The interaction between ER and NFκB in resistance to endocrine therapy. Breast Cancer Res 2012 0.90
38 Krüppel-like factors in cancer progression: three fingers on the steering wheel. Oncotarget 2014 0.90
39 Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. Cancer Invest 2008 0.89
40 Re: Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor: Direct evidence of mutational inactivation of SMARCB1/INI1 in epithelioid sarcoma. Hum Pathol 2009 0.88
41 Quantitative and phenotypic analysis of mesenchymal stromal cell graft survival and recognition by microglia and astrocytes in mouse brain. Immunobiology 2012 0.88
42 Single-photon emission computed tomographic imaging of the early time course of therapy-induced cell death using technetium 99m tricarbonyl His-annexin A5 in a colorectal cancer xenograft model. Mol Imaging 2012 0.87
43 Recognition of cellular implants by the brain's innate immune system. Immunol Cell Biol 2010 0.87
44 Cell type-associated differences in migration, survival, and immunogenicity following grafting in CNS tissue. Cell Transplant 2012 0.87
45 Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response. BMC Res Notes 2014 0.87
46 Labeling of Luciferase/eGFP-expressing bone marrow-derived stromal cells with fluorescent micron-sized iron oxide particles improves quantitative and qualitative multimodal imaging of cellular grafts in vivo. Mol Imaging Biol 2011 0.87
47 Postextubation obstructive pseudomembranes: a case series and review of a rare complication after endotracheal intubation. Lung 2010 0.86
48 Onartuzumab in lung cancer: the fall of Icarus? Expert Rev Anticancer Ther 2015 0.83
49 Relationship between pathological features, HER2 protein expression and HER2 and CEP17 copy number in breast cancer: biological and methodological considerations. J Clin Pathol 2010 0.83
50 Clear-cell variant of solid-pseudopapillary neoplasm of the pancreas: a case report and review of the literature. Malays J Pathol 2009 0.83
51 One-stage penectomy and phalloplasty for epithelioid sarcoma of the penis in an adolescent: part 2. Eur Urol 2007 0.82
52 The extracellular matrix regulates cancer progression and therapy response: implications for prognosis and treatment. Curr Pharm Des 2009 0.82
53 The radiosensitising effect of gemcitabine and its main metabolite dFdU under low oxygen conditions is in vitro not dependent on functional HIF-1 protein. BMC Cancer 2014 0.81
54 Expression analysis on archival material: comparison of 5 commercially available RNA isolation kits for FFPE material. Diagn Mol Pathol 2011 0.81
55 Identification of CUX1 as the recurrent chromosomal band 7q22 target gene in human uterine leiomyoma. Genes Chromosomes Cancer 2012 0.81
56 Detection of ALK expression in non-small-cell lung cancer with ALK gene rearrangements--comparison of multiple immunohistochemical methods. Histopathology 2014 0.80
57 Expression and prognostic value of glucose transporters and hexokinases in tonsil and mobile tongue squamous cell carcinoma. Histol Histopathol 2011 0.80
58 Expression of hexokinases and glucose transporters in treated and untreated oesophageal adenocarcinoma. Histol Histopathol 2009 0.79
59 Sarcomatous degeneration in fibrous dysplasia of the rib cage. Ann Thorac Surg 2013 0.78
60 MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option? Virchows Arch 2010 0.78
61 An immunohistochemical analysis of Rab27B distribution in fetal and adult tissue. Int J Dev Biol 2012 0.78
62 Carbonic anhydrase IX expression correlates with FDG uptake by primary non-small cell lung cancer. Cancer Biother Radiopharm 2010 0.77
63 Looking for a new panacea in ALK-rearranged NSCLC: may be Ceritinib? Expert Opin Ther Targets 2014 0.77
64 The presence of Y chromosomal deoxyribonucleic acid in the female vaginal swab: possible implications for human papillomavirus testing. Cancer Epidemiol 2010 0.77
65 Smooth muscle cell transplantation improves bladder contractile function in streptozocin-induced diabetic rats. Cytotherapy 2013 0.76
66 Complex genetic alterations in gastrointestinal stromal tumors with autonomic nerve differentiation. Mod Pathol 2002 0.75
67 One-stage penectomy and phalloplasty for epithelioid sarcoma of the penis in an adolescent. Eur Urol 2006 0.75
68 Combined effect of EPO and radiotherapy on the expression of endogenous molecular markers of tumor metabolism and metastasis. Cancer Biother Radiopharm 2009 0.75
69 Isolated lung perfusion with gemcitabine combined with radiotherapy: no additional lung toxicity in an experimental model. Eur J Cardiothorac Surg 2012 0.75
70 The role of cMet in non-small cell lung cancer resistant to EGFR-inhibitors: did we really find the target? Curr Drug Targets 2014 0.75
71 Differences in imiquimod treatment outcome in two patients with bowenoid papulosis containing either episomal or integrated human papillomavirus 16. J Invest Dermatol 2006 0.75